Cite
MLA Citation
Prajwal Dhakal et al.. “Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?.” Leukemia & lymphoma, vol. 61, no. 1, 2020, pp. 7–17. http://access.bl.uk/ark:/81055/vdc_100098772848.0x000033